InvestorsHub Logo

ziploc_1

06/10/22 10:42 AM

#379948 RE: HDGabor #379939

HDG...Thank you...I am surprised THAT
...
1. The net price in Q4 2020 was as low as $135.91
2. The authorities in Sweden and UK agreed to pay the reported prices .
3. Generics can compete at this price level
4. Amarin has not already seen fit to issue an AG at this price level

Whalatane

06/12/22 12:45 PM

#380133 RE: HDGabor #379939

HDG. thx for this DD .
So aren't we effectively becoming generic " like " in the US without an actual authorized generic ?
Sales , marketing drastically cut ...pricing to compete with generics ( increased rebates etc ) to maintain exclusivity ?

Kiwi